Absolutely no need to merge: AV is a potential game changerOn Feb. 3, 2023 Gilles made the following statement which is paraphrased below;
" ....have long time shareholders, grateful for them, large hangover, will keep shares for grandchildren, people will come to table when they execute, if we succeed with AV phase 1/2a in 12 – 15 months, out license to pharma will be a game changer, much bigger than CoQ10 "
Results for safety and optimal dosage are due in September. Given AV are widely found in oats and consumed, this phase of the clinical study should be successful. Why would long term suffering, valued shareholders like OATS want to dilute their holdings (in a sham merger) in a potential game changer?
OATS, vote NO to this sham merger and reap the potential benefits of waiting it out.